(09:20) The U.S. Food and Drug Administration announced a recall of Mylan’s EpiPen and EpiPen Jr. The emergency injectors could fail to activate because of a defective part. Mylan distributed the 13 affected lots between December 2015 and July 2016. The auto-injectors help treat severe allergic reactions with a dose of epinephrine. The recall includes both the 0.3 and 0.15 mg strengths of EpiPen, but not the generic version. Both the FDA and Mylan encourage people to keep and use their current EpiPens until they receive a replacement. Customers can check their EpiPens against Mylan’s list of affected lot numbers and return any recalled products by calling Stericycle at 877-650-3494.
